Dow Up 0.36% Nasdaq Up 0.12%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.19 Down 0.02(1.65%) Aug 21, 4:00PM EDT
Prev Close:1.21
Open:1.20
Bid:1.16 x 5000
Ask:1.23 x 1800
1y Target Est:3.10
Beta:1.89
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.18 - 1.22
52wk Range:1.18 - 5.19
Volume:948,332
Avg Vol (3m):2,490,760
Market Cap:167.84M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXDown 1.65%167.84M
AZNUp 3.08%92.44B
GSKDown 0.23%114.58B
PFEDown 0.24%182.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback